Newsletter
Ep. 94: Securing Clinical Trial Documentation – Hadil Es-Sbai (CEO Triall)

Health Unchained

Ep. 94: Securing Clinical Trial Documentation – Hadil Es-Sbai (CEO Triall)

Securing Clinical Trial Documentation
May 7, 2022

Ep. 94: Securing Clinical Trial Documentation – Hadil Es-Sbai (CEO Triall)

Hadil Es-Sbai is on a mission to make clinical trial data more secure and accessible. His

company, Triall, is attempting to revolutionize the clinical trial industry. They’re building an

easy and secure way for researchers to conduct trials as well as for participants to

stay engaged. Hadil shares why blockchain solutions are a perfect match for an industry like

clinical research and how it can make the transition to Web3.

Topics Covered:

  • How Hadil got into blockchain after working over 20 years in the clinical research industry
  • The different blockchain integrated e-clinical solutions that Triall is developing
  • How blockchain solutions can help streamline clinical development activities
  • Using LTO Network, Accumulate – but blockchain agnostic  
  • The ways Triall is making it easier for participants and researchers to complete
  • clinical trials
  • How Triall is ensuring patient privacy and also accessibility for researchers
  • Triall’s ICO and TRL token
  • Roadmap for the future of their platform

About the Guest

Connect with Hadil

Learn more about Triall

Resources Mentioned

CR2O

Sphereon

The 48 Laws of Power

News Corner

Louisiana sues UnitedHealthcare, OptumRx for alleged Medicaid drug overcharging – https://digitalhealth.modernhealthcare.com/technology/louisiana-sues-unitedhealthcare-optumrx-alleged-medicaid-drug-overcharging

Hyperledger – Healthcare Special Interest Group Meetings

https://wiki.hyperledger.org/display/HCSIG/HC-SIG+General+Meetings

Health Unchained Links

Website: https://healthunchained.org

Telegram: t.me/healthunchained

Twitter: twitter.com/Healthunchaind

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
What Will Variant Sigma Look Like? with Michael T. Osterholm, Ph.D., Regents Professor, Division of Environmental Health Science; Director, Center for Infectious Disease Research and Policy (CIDRAP) University of Minnesota